160 related articles for article (PubMed ID: 30249921)
1. Perioperative Sildenafil Therapy in Pediatric Congenital Cardiac Disease Patients.
Jiang L; Sun W; Zhang K; Zhou B; Kong X
Int Heart J; 2018 Nov; 59(6):1333-1339. PubMed ID: 30249921
[TBL] [Abstract][Full Text] [Related]
2. Perioperative sildenafil therapy in pulmonary hypertension associated with congenital cardiac disease: An updated meta-analysis.
Usmani SUR; Hasan SU; Ali SH; Ahmed SH; Pervez N; Danial M; Khan O; Tucker DL; Zubair MM
Asian J Surg; 2024 Jun; 47(6):2551-2557. PubMed ID: 38531747
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.
Sabri MR; Bigdelian H; Hosseinzadeh M; Ahmadi A; Ghaderian M; Shoja M
Cardiol Young; 2017 Nov; 27(9):1686-1693. PubMed ID: 28994364
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials.
Awad AK; Gad ER; Abdelgalil MS; Elsaeidy AS; Ahmed O; Elbadawy MA
BMC Pediatr; 2023 Jul; 23(1):372. PubMed ID: 37474896
[TBL] [Abstract][Full Text] [Related]
5. Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children? - a prospective randomized study.
Sharma VK; Joshi S; Joshi A; Kumar G; Arora H; Garg A
Ann Card Anaesth; 2015; 18(4):510-6. PubMed ID: 26440237
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Sildenafil in Pediatric Patients Undergoing Congenital Heart Surgeries: A Systematic Review and Meta-Analysis.
Fikri YA; Mulia EPB; Nugroho FW
Semin Cardiothorac Vasc Anesth; 2023 Dec; 27(4):252-259. PubMed ID: 37844905
[No Abstract] [Full Text] [Related]
7. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil Use in Children with Pulmonary Hypertension.
Cohen JL; Nees SN; Valencia GA; Rosenzweig EB; Krishnan US
J Pediatr; 2019 Feb; 205():29-34.e1. PubMed ID: 30396684
[TBL] [Abstract][Full Text] [Related]
9. Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis.
Wu X; Yang T; Zhou Q; Li S; Huang L
Eur J Heart Fail; 2014 Apr; 16(4):444-53. PubMed ID: 24464734
[TBL] [Abstract][Full Text] [Related]
10. Associations Between Sildenafil Use and Changes in Days of Hospitalization in a Population With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
Yang X; Sanders KN; Mardekian J; Mychaskiw MA; Thomas J
Clin Ther; 2015 May; 37(5):1055-63. PubMed ID: 25818118
[TBL] [Abstract][Full Text] [Related]
11. Routine Sildenafil Does Not Improve Clinical Outcomes After Fontan Operation.
Collins JLG; Law MA; Borasino S; Erwin WC; Cleveland DC; Alten JA
Pediatr Cardiol; 2017 Dec; 38(8):1703-1708. PubMed ID: 28884212
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis.
Pan W; Wang Y; Lin L; Zhou G; Hua X; Mo L
Paediatr Anaesth; 2016 Mar; 26(3):239-48. PubMed ID: 26612740
[TBL] [Abstract][Full Text] [Related]
13. Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysis.
Chen J; Gong X; Chen P; Luo K; Zhang X
BMC Pregnancy Childbirth; 2016 Aug; 16():225. PubMed ID: 27528012
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Hypertension Therapy and a Systematic Review of Efficacy and Safety of PDE-5 Inhibitors.
Unegbu C; Noje C; Coulson JD; Segal JB; Romer L
Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28235796
[TBL] [Abstract][Full Text] [Related]
15. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide: perioperative patterns in congenital heart disease.
Niedner MF; Foley JL; Riffenburgh RH; Bichell DP; Peterson BM; Rodarte A
Congenit Heart Dis; 2010; 5(3):243-55. PubMed ID: 20576043
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Sildenafil treatment in pulmonary hypertension caused by chronic obstructive pulmonary disease: A meta-analysis.
Hao Y; Zhu Y; Mao Y; Xu J; He X; Huang S; Wang M; Qiu J
Life Sci; 2020 Sep; 257():118001. PubMed ID: 32634428
[TBL] [Abstract][Full Text] [Related]
18. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children.
Nemoto S; Sasaki T; Ozawa H; Katsumata T; Kishi K; Okumura K; Mori Y; Umegaki O
Eur J Cardiothorac Surg; 2010 Jul; 38(1):71-7. PubMed ID: 20206543
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil in Term and Premature Infants: A Systematic Review.
Perez KM; Laughon M
Clin Ther; 2015 Nov; 37(11):2598-2607.e1. PubMed ID: 26490498
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Infants with Bronchopulmonary Dysplasia.
Trottier-Boucher MN; Lapointe A; Malo J; Fournier A; Raboisson MJ; Martin B; Moussa A
Pediatr Cardiol; 2015 Aug; 36(6):1255-60. PubMed ID: 25824807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
